当前位置:首页 - 行情中心 - 奥翔药业(603229) - 财务分析 - 现金流量表

奥翔药业

(603229)

  

流通市值:58.20亿  总市值:58.20亿
流通股本:8.30亿   总股本:8.30亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金500,818,898.77268,793,451.83124,035,737.44881,351,859.33
  收到的税费返还20,005,696.9816,069,012.47143,941.881,727,029.7
  收到其他与经营活动有关的现金82,916,316.3464,643,012.5664,200,585.02101,167,997.7
  经营活动现金流入小计603,740,912.09349,505,476.86188,380,264.34984,246,886.73
  购买商品、接受劳务支付的现金234,468,255.72194,886,416.999,316,564.87377,408,767.45
  支付给职工以及为职工支付的现金204,383,999.6133,817,508.3876,515,403.1211,547,810.19
  支付的各项税费25,642,460.2724,034,419.744,635,845.7542,615,285.89
  支付其他与经营活动有关的现金82,875,709.2339,130,384.4341,947,428.61196,166,108.95
  经营活动现金流出小计547,370,424.82391,868,729.45222,415,242.33827,737,972.48
  经营活动产生的现金流量净额56,370,487.27-42,363,252.59-34,034,977.99156,508,914.25
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额---109,013.45
  收到的其他与投资活动有关的现金19,801,399.8929,446,426.648,887,293.0866,925,007.52
  投资活动现金流入小计19,801,399.8929,446,426.648,887,293.0867,034,020.97
  购建固定资产、无形资产和其他长期资产支付的现金73,477,114.445,446,809.5625,228,160.11104,445,390.34
  支付其他与投资活动有关的现金16,267,079.498,976,423.144,951,851.5721,011,807.99
  投资活动现金流出小计89,744,193.8954,423,232.730,180,011.68125,457,198.33
  投资活动产生的现金流量净额-69,942,794-24,976,806.06-21,292,718.6-58,423,177.36
三、筹资活动产生的现金流量:
  取得借款收到的现金238,929,606.9215,018,040101,000,000505,180,810.84
  收到其他与筹资活动有关的现金16,083,021.041,357,855.24602,116.4819,336,915.6
  筹资活动现金流入小计255,012,627.94216,375,895.24101,602,116.48524,517,726.44
  偿还债务支付的现金379,700,810.84309,445,810.8471,045,810.84320,355,000
  分配股利、利润或偿付利息支付的现金60,321,615.165,631,968.83,337,074.7190,623,943.62
  支付其他与筹资活动有关的现金16,236,703.9416,236,603.9419,589,149.3863,087,428.2
  筹资活动现金流出小计456,259,129.94331,314,383.5893,972,034.93474,066,371.82
  筹资活动产生的现金流量净额-201,246,502-114,938,488.347,630,081.5550,451,354.62
四、汇率变动对现金及现金等价物的影响-51,508,010.28-33,254,046.82-22,048,408.04-17,457,141.89
五、现金及现金等价物净增加额-266,326,819.01-215,532,593.81-69,746,023.08131,079,949.62
  加:期初现金及现金等价物余额1,179,661,168.771,179,661,168.771,179,661,168.771,048,581,219.15
  期末现金及现金等价物余额913,334,349.76964,128,574.961,109,915,145.691,179,661,168.77
补充资料:
  净利润-119,840,785.42-130,570,123.6
  资产减值准备-2,186,481.64-19,583,678.95
  固定资产和投资性房地产折旧-40,914,003.9-72,038,987.35
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-40,914,003.9-72,038,987.35
  无形资产摊销-1,033,872.64-2,150,081.02
  固定资产报废损失---1,482,914.86
  公允价值变动损失--26,427,338.21-489,448.22
  财务费用-43,104,744.34-28,695,012.24
  投资损失--10,766,110.31--22,281,446.94
  递延所得税--3,908,236.68--3,359,175.1
  其中:递延所得税资产减少--3,908,236.68--3,359,175.1
  存货的减少-26,324,440.16--16,934,028.94
  经营性应收项目的减少--333,524,777.94--9,119,596.86
  经营性应付项目的增加-83,232,095.19--42,401,299.36
  其他----87,556.43
  现金的期末余额-964,128,574.96-1,179,661,168.77
  减:现金的期初余额-1,179,661,168.77-1,048,581,219.15
  现金及现金等价物的净增加额--215,532,593.81-131,079,949.62
公告日期2026-10-312026-08-292026-04-292026-04-29
审计意见(境内)标准无保留意见
TOP↑